Son; Moon Ho

Patent Applications and Registrations

Patent applications and USPTO patent grants for Son; Moon Ho.The latest application filed is for "compound having gpr119 agonistic activity, method for preparing the same, and pharmaecutical composition including the same as effective component".

Company Profile

2.6.10

Son; Moon Ho - Gyeonggi-do KR
Son; Moon Ho - Geoje-si KR
Son; Moon-Ho - Suwon-si N/A KR
Son; Moon Ho - Suwon KR
Son, Moon Ho - Suwon-city KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted piperidines having GPR119 agonistic activity Grant 10,428,055 - Yang , et al. October 1, 2	2019-10-01
Compound Having Gpr119 Agonistic Activity, Method For Preparing The Same, And Pharmaecutical Composition Including The Same As Effective Component App 20190092763 - Yang; Jae Sung ; et al.	2019-03-28
Composition containing a DPP-IV inhibitor for preventing or treating renal diseases Grant 10,159,667 - Cha , et al. Dec	2018-12-25
Composition Containing A Dpp-iv Inhibitor For Preventing Or Treating Renal Diseases App 20160184300 - CHA; Dae Ryong ; et al.	2016-06-30
Waste Heat Recovery Device For A Marine Vessel App 20140345280 - Son; Moon Ho ; et al.	2014-11-27
Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients Grant 8,440,669 - Shin , et al. May 14, 2	2013-05-14
Pharmaceutical Composition For The Prevention Or The Treatment Of Non-alcoholic Fatty Liver Disease And The Method For Prevention Or Treatment Of Non-alcoholic Fatty Liver Disease Using The Same App 20130072459 - An; Gook-Jun ; et al.	2013-03-21
DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating diabetes or obesity Grant 8,030,315 - Kim , et al. October 4, 2	2011-10-04
Pharmaceutical Composition for Prevention and Treatment of Diabetes or Obesity Comprising a Compound that Inhibits Activity of Dipeptidyl Peptidase-IV, and other Antidiabetic or Antiobesity Agents as Active Ingredients App 20110201624 - Shin; Chang Yell ; et al.	2011-08-18
Dpp-iv Inhibitor Including Beta-amino Group, Preparation Method Thereof And Pharmaceutical Composition Containing The Same For Preventing And Treating Diabetes Or Obesity App 20100120790 - Kim; Heung Jae ; et al.	2010-05-13
Novel Phenylpropionic Acid Derivatives As Peroxisome Proliferator-activated Gamma Receptor Modulators, Method Of The Same, And Pharmaceutical Composition Comprising The Same App 20100063041 - Moon; Ho-Sang ; et al.	2010-03-11
1-phenylpiperidin-3-one derivatives and processes for the preparation thereof Grant 7,342,027 - Lee , et al. March 11, 2	2008-03-11
1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof App 20050234057 - Lee, Jong Wook ; et al.	2005-10-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.